Press Releases

SAN DIEGO, Nov. 13, 2019 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, announced today that Chief Executive Officer Saundra Pelletier will present at two upcoming healthcare equity conferences:

ATLANTA, Nov. 13, 2019 /PRNewswire/ -- Regional Health Properties, Inc. (NYSE American: RHE) (NYSE American: RHEpA), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care, yesterday reported results for the three and nine months ended September 30, 2019

SAN DIEGO, Nov. 13, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable i

SAN DIEGO, Nov. 13, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics, will

SAN FRANCISCO, Nov. 13, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced that members of the management team will provide a business overview and update at the Je

SALT LAKE CITY, Nov. 13, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the launch of a pub

HARTFORD, Conn., Nov. 13, 2019 /PRNewswire/ -- CareCentrix, the leading provider of in home-based post-acute-care solutions, put out a statement today in support of

MARINA DEL REY, Calif., Nov. 13, 2019 /PRNewswire/ -- Heritage Provider Network (HPN) one of the nations most experienced and innovative physician led value-based care organizations, and its family of medical groups saw rankings soar from America's Physician Groups (APG) annual Standards of Excellence™ (SOE®) survey.  All 9 medical groups earned Elite

WALTHAM, Mass., Nov. 13, 2019 /PRNewswire/ -- Dragonfly Therapeutics, Inc. ("Dragonfly" or the "Company"), today announced it has licensed another TriNKET™ immunotherapy drug candidate to Celgene Corporation and its affiliates ("Celgene").  Today's announcement marks the third opt-in executed by Celgene since the companies announced a collaboration focuse

LEWISVILLE, N.C., Nov. 13, 2019 /PRNewswire/ -- Gryphon House, Inc. announces